Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medidata Reports First Quarter 2018 Results
Total revenue of $149.2 million , representing 17% year-over-year growth GAAP operating margin of 8.9%; non-GAAP operating margin of 22.9%, representing 120 basis points year-over-year margin expansion Total multi-year subscription backlog, unadjusted for renewals, of $1.0 billion as of March 31,
View HTML
Toggle Summary Medidata Schedules First Quarter Earnings Conference Call for April 19, 2018
NEW YORK --(BUSINESS WIRE)--Apr. 5, 2018-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2018 financial results before the open of the market on Thursday, April 19, 2018
View HTML
Toggle Summary Australia NHMRC Clinical Trials Centre Partners with Medidata to Digitize Cancer Research
Leading Australian clinical trials centre adopts Medidata Clinical Cloud ® to accelerate clinical research SYDNEY & NEW YORK --(BUSINESS WIRE)--Apr. 3, 2018-- Medidata (NASDAQ: MDSO) announced that the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), University of
View HTML
Toggle Summary Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
Where Life Sciences Leaders Meet Transformative Technology Meets the Future LONDON --(BUSINESS WIRE)--Mar. 28, 2018-- Medidata (NASDAQ:MDSO) successfully hosted NEXT conferences in Basel and Frankfurt , with executives from global life sciences and pharmaceutical companies presenting, including
View HTML
Toggle Summary How Do Technology and Data Accelerate Precision Medicine in Oncology? Industry Experts to Discuss During Medidata Webinar
NEW YORK --(BUSINESS WIRE)--Mar. 15, 2018-- Oncology is leading the precision medicine revolution, as clinical researchers leverage and identify biomarkers to target patient subsets with more effective treatments, and the promise of improving Phase I success rate probability by three times (25.9%
View HTML
Toggle Summary Medidata to Present at Morgan Stanley Technology, Media & Telecom Conference
NEW YORK --(BUSINESS WIRE)--Feb. 21, 2018-- Medidata (NASDAQ:MDSO) today announced that Tarek Sherif , chief executive officer, and Rouven Bergmann , chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, February 28, 2018 , at 11:15 a.m.
View HTML
Toggle Summary Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development
Company adopts Edge CTMS in Japan as part of rapid global expansion NEW YORK --(BUSINESS WIRE)--Feb. 20, 2018-- Santen Pharmaceutical Co., Ltd , is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial
View HTML
Toggle Summary Medidata and eClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement to Adopt Medical Imaging and Workflow Solutions
Industry-leading Data Management Provider Adopts Rave Imaging to Optimize Workflow, Simplify Image and Data Collection, and Improve Efficiency in Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 15, 2018-- Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC , an
View HTML
Toggle Summary Medidata Named One of 100 Most Sustainable Companies in the U.S. by Barron's Magazine
NEW YORK --(BUSINESS WIRE)--Feb. 14, 2018-- Medidata (NASDAQ:MDSO) has been named to Barron’s first annual list of the “ 100 Most Sustainable Companies ” in the U.S., demonstrating the company's positive impact in five categories: shareholders, employees, customers, community and planet.
View HTML
Toggle Summary Aperio Adds Medidata Edge eTMF and CTMS in Expansion Agreement
Leading clinical research organization moves to the industry’s only unified platform to maximize efficiencies and outcomes NEW YORK --(BUSINESS WIRE)--Feb. 13, 2018-- Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the
View HTML

Investor Contact

Betsy Frank
+1 917 522 4620
bfrank@mdsol.com